Literature DB >> 3503556

In vivo hydroxyapatite formation induced by lipids.

C L Raggio1, B D Boyan, A L Boskey.   

Abstract

Proteolipids and complexed acidic phospholipids that cause in vitro hydroxyapatite formation, similarly cause hydroxyapatite deposition in 10-mu pore Millipore chambers when implanted in rabbit muscle pouches. The amount of mineral deposited during a 3-week period, based on the calcium and phosphate contents of the chambers, was directly related to the dry weight of the lipid implanted in the chamber. Chambers containing total lipid extract from rabbit bone from which the complexed acidic phospholipids had been removed, acidic phospholipids from which the the proteolipids had been removed, and empty chambers did not accumulate any detectable mineral during the course of the study. Chambers implanted with synthetic hydroxyapatite served as controls for chemical analyses. The presence of hydroxyapatite in the chambers was established 3 weeks after implantation based on electron microscopic, compositional, and wide-angle X-ray diffraction analyses of the deposits. In the cell-free chambers, lipid-induced hydroxyapatite deposition, but not bone matrix formation occurred. This study demonstrates that proteolipids and complexed acidic phospholipids can cause hydroxyapatite mineral deposition in a physiologic environment. To date, these lipids are the only materials isolated from mineralizing tissues, other than reconstituted collagen, that have been shown capable of causing in vivo mineralization in the absence of cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3503556     DOI: 10.1002/jbmr.5650010505

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

1.  Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans.

Authors:  D D Dean; Z Schwartz; O E Muniz; R Gomez; L D Swain; D S Howell; B D Boyan
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  In vivo assessment of the osteointegrative potential of phosphatidylserine-based coatings.

Authors:  A Merolli; M Bosetti; L Giannotta; A W Lloyd; S P Denyer; W Rhys-Williams; W G Love; C Gabbi; A Cacchioli; P Tranquilli Leali; M Cannas; M Santin
Journal:  J Mater Sci Mater Med       Date:  2006-09       Impact factor: 3.896

Review 3.  Biomineralization and matrix vesicles in biology and pathology.

Authors:  Ellis E Golub
Journal:  Semin Immunopathol       Date:  2010-12-08       Impact factor: 9.623

4.  Persistence of complexed acidic phospholipids in rapidly mineralizing tissues is due to affinity for mineral and resistance to hydrolytic attack: in vitro data.

Authors:  A L Boskey; W Ullrich; L Spevak; H Gilder
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

Review 5.  Role of matrix vesicles in biomineralization.

Authors:  Ellis E Golub
Journal:  Biochim Biophys Acta       Date:  2009-09-26

6.  The effect of phosphatidylserine on in vitro hydroxyapatite growth and proliferation.

Authors:  A L Boskey; B L Dick
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

7.  Calcium-acidic phospholipid-phosphate complexes in human hydroxyapatite-containing pathologic deposits.

Authors:  A L Boskey; P G Bullough; V Vigorita; E Di Carlo
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

8.  Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner.

Authors:  D D Dean; B D Boyan; O E Muniz; D S Howell; Z Schwartz
Journal:  Calcif Tissue Int       Date:  1996-08       Impact factor: 4.333

9.  Iodoplatinate visualization of phospholipids in rat incisor predentine and dentine, compared with malachite green aldehyde.

Authors:  L Vermelin; D Septier; M Goldberg
Journal:  Histochemistry       Date:  1994-01

10.  An ultrastructural study of the effects of acidic phospholipid substitutions on calcium phosphate precipitation in anionic liposomes.

Authors:  B R Heywood; E D Eanes
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.